» Articles » PMID: 26463451

Fibrotic-like Changes in Degenerate Human Intervertebral Discs Revealed by Quantitative Proteomic Analysis

Overview
Date 2015 Oct 15
PMID 26463451
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Intervertebral disc degeneration (IDD) can lead to symptomatic conditions including sciatica and back pain. The purpose of this study is to understand the extracellular matrix (ECM) changes in disc biology through comparative proteomic analysis of degenerated and non-degenerated human intervertebral disc (IVD) tissues of different ages.

Design: Seven non-degenerated (11-46 years of age) and seven degenerated (16-53 years of age) annulus fibrosus (AF) and nucleus pulposus (NP) samples were used. Proteins were extracted using guanidine hydrochloride, separated from large proteoglycans (PGs) by caesium chloride (CsCl) density gradient ultracentrifugation, and identified using liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS). For quantitative comparison, proteins were labeled with iTRAQ reagents. Collagen fibrils in the NP were assessed using scanning electron microscopy (SEM).

Results: In the AF, quantitative analysis revealed increased levels of HTRA1, COMP and CILP in degeneration when compared with samples from older individuals. Fibronectin showed increment with age and degeneration. In the NP, more CILP and CILP2 were present in degenerated samples of younger individuals. Reduced protein solubility was observed in degenerated and older non-degenerated samples correlated with an accumulation of type I collagen in the insoluble fibers. Characterization of collagen fibrils in the NP revealed smaller mean fibril diameters and decreased porosity in the degenerated samples.

Conclusions: Our study identified distinct matrix changes associated with aging and degeneration in the intervertebral discs (IVDs). The nature of the ECM changes, together with observed decreased in solubility and changes in fibril diameter is consistent with a fibrotic-like environment.

Citing Articles

CILP-2 expression in the intervertebral discs of patients with lumbar radiculopathy.

Koiv K, Aunapuu M, Torga T, Ratsep T, Bakhoff K, Arend A BMC Musculoskelet Disord. 2024; 25(1):882.

PMID: 39506696 PMC: 11539541. DOI: 10.1186/s12891-024-07996-9.


A new perspective on intervertebral disc calcification-from bench to bedside.

Novais E, Narayanan R, Canseco J, van de Wetering K, Kepler C, Hilibrand A Bone Res. 2024; 12(1):3.

PMID: 38253615 PMC: 10803356. DOI: 10.1038/s41413-023-00307-3.


Machine learning algorithm predicts fibrosis-related blood diagnosis markers of intervertebral disc degeneration.

Zhao W, Wei J, Ji X, Jia E, Li J, Huo J BMC Med Genomics. 2023; 16(1):274.

PMID: 37915003 PMC: 10619283. DOI: 10.1186/s12920-023-01705-6.


Umbilical cord mesenchymal stem cells for regenerative treatment of intervertebral disc degeneration.

Huang H, Liu X, Wang J, Suo M, Zhang J, Sun T Front Cell Dev Biol. 2023; 11:1215698.

PMID: 37601097 PMC: 10439242. DOI: 10.3389/fcell.2023.1215698.


Biomarkers and longitudinal changes in lumbar spine degeneration and low back pain: the Johnston County Osteoarthritis Project.

Goode A, Cleveland R, Kraus V, Taylor K, George S, Schwartz T Osteoarthritis Cartilage. 2023; 31(6):809-818.

PMID: 36804589 PMC: 10200763. DOI: 10.1016/j.joca.2023.02.005.